Molina Healthcare - MOH Stock Forecast, Price & News

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Molina Healthcare Price Performance

Shares of NYSE:MOH opened at $332.43 on Friday. The company has a 50 day moving average of $291.76 and a 200 day moving average of $307.07. The stock has a market cap of $19.31 billion, a P/E ratio of 25.89, a P/E/G ratio of 1.14 and a beta of 0.85. Molina Healthcare has a 12 month low of $244.75 and a 12 month high of $350.19. The company has a current ratio of 1.43, a quick ratio of 1.43 and a debt-to-equity ratio of 0.84.

Molina Healthcare (NYSE:MOH - Get Rating) last released its quarterly earnings results on Wednesday, July 27th. The company reported $4.55 EPS for the quarter, topping analysts' consensus estimates of $4.34 by $0.21. Molina Healthcare had a net margin of 2.48% and a return on equity of 32.97%. The business had revenue of $8.05 billion during the quarter, compared to analysts' expectations of $7.69 billion. During the same quarter in the previous year, the company earned $3.40 EPS. The business's quarterly revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Molina Healthcare will post 17.63 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Bank of America lowered shares of Molina Healthcare from a "buy" rating to an "underperform" rating and lowered their price objective for the stock from $355.00 to $335.00 in a research report on Thursday, May 26th. Cowen lifted their price objective on shares of Molina Healthcare from $356.00 to $366.00 in a research report on Monday, May 2nd. Credit Suisse Group set a $321.00 price objective on shares of Molina Healthcare in a research report on Tuesday, July 19th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Molina Healthcare from $311.00 to $315.00 in a research report on Monday, August 1st. Finally, Wells Fargo & Company lowered their price objective on shares of Molina Healthcare from $308.00 to $301.00 and set an "underweight" rating on the stock in a research report on Wednesday, May 25th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Molina Healthcare has a consensus rating of "Moderate Buy" and an average target price of $341.00.

Insider Transactions at Molina Healthcare

In other news, insider Jeff D. Barlow sold 90 shares of the business's stock in a transaction that occurred on Tuesday, August 9th. The shares were sold at an average price of $333.01, for a total value of $29,970.90. Following the completion of the sale, the insider now directly owns 81,146 shares in the company, valued at approximately $27,022,429.46. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, insider Jeff D. Barlow sold 90 shares of the company's stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $333.01, for a total transaction of $29,970.90. Following the completion of the sale, the insider now directly owns 81,146 shares in the company, valued at approximately $27,022,429.46. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP James Woys sold 25,000 shares of the company's stock in a transaction on Wednesday, August 3rd. The shares were sold at an average price of $328.11, for a total transaction of $8,202,750.00. Following the sale, the executive vice president now owns 37,810 shares of the company's stock, valued at $12,405,839.10. The disclosure for this sale can be found here. In the last ninety days, insiders sold 39,826 shares of company stock worth $13,089,848. 1.49% of the stock is currently owned by insiders.